Recro Pharma

-$0.05 (-2.38%) Today
$0.00 (0.00%) As of 11:16 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Recro Pharma and other ETFs, options, and stocks.

About REPH

Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The firm offers integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products.

CEO
J. David Enloe
Employees
185
Headquarters
Exton, Pennsylvania
Founded
2007

REPH Key Statistics

Market Cap
95.56M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
276.21K
High Today
$2.17
Low Today
$2.01
Open Price
$2.09
Volume
202.44K
52 Week High
$5.29
52 Week Low
$1.49

REPH News

MarketWatchSep 21

Recro Pharma Signs Renewable Energy Agreement with Georgia Power

By Michael Dabaie Recro Pharma Inc. said it signed a renewable energy agreement with Georgia Power to purchase 1.2 million renewable energy credits through Geo
BenzingaSep 16

Recro Pharma's Return On Capital Employed Overview

According to Benzinga Pro, during Q2, Recro Pharma (NASDAQ:REPH) earned $1.84 million, a 164.34% increase from the preceding quarter. Recro Pharma also posted a

REPH Earnings

-$0.48
-$0.31
-$0.14
$0.03
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure